I recently learned of Eli Lilly & Co.’s (“Lilly”) recent lawsuit against FDA from Nicole DeFeudis, who interviewed me for her ...

The decision will largely prevent compounding pharmacies from making and selling compounded versions of the drug in the next two to three months.

Researchers from Canada reviewed the results of 26 trials to determine which of the weight loss jabs are the most effective ...

The FDA is allowing pharmacies to dispense compounded versions of semaglutide and tirzepatide until shortages of the brand-name drugs are fully resolved. In October, the FDA said compounding ...

Earlier in December, telehealth company Ro announced a partnership with Eli Lilly to offer a half-price version of Zepbound, Lilly's brand-name tirzepatide product. The cheaper option is sold in ...

"We're suckers for quick fixes," Emily Feivor, a registered dietician, tells PEOPLE about the claim that honey, lemon, water, ...

Patients taking a compounded alternative to Eli Lilly's weight loss drug Zepbound will need to transition to the name-brand version ... years of being in shortage, tirzepatide — the active ...

This may start to bring down the cost of brand-name competitors—here's who might get access, and one major difference from ...

On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a declaratory order determining that the shortage of diabetes and ...

The FDA has declared an end to the shortage of a popular obesity drug. The implications for consumers are complicated.

Now that the FDA has decided tirzepatide is no longer in shortage ... officials have raised concerns about the prices of brand-name glucagon-like peptide 1, or GLP-1. medications, and some ...

Ready to crush your New Year’s health goals? These breakthrough medications offer more than weight loss—they support your ...